Survey respondents who say they are currently getting positive results or recoveries from their FDA tools are more likely to: 01 Use advanced technology Companies that successfully deploy FDA harness sophisticated analytics tools. A much higher percentage of those who report positive results are using social media, web monitoring and visualization tools. 56% Figure 12: The use of advanced FDA technologies agree Visualization 29% “ We currently get positive results 20% or recoveries from the FDA tools Social media 30% that we use.” 14% Statistical analysis 7% 2% Agree Disagree �▀ ▀ Q. What tools do you utilize in managing fraud risk? Base: Among all respondents (665), 56% (370) agree and 21% (140) disagree that “We currently get positive results from the FDA tools that we use.” Multiple answers allowed, may exceed 100%. 02 Analyze large data volumes More powerful analytics tools allow organizations to analyze more data, both in terms of volume and variety. Our survey shows a high correlation between reports of positive results and the use of large data volumes. Seventy-nine percent of those reporting positive results, versus 11% of those who don’t, are using more than 10 million records, which are typically outside the domain of spreadsheets and thus require more sophisticated tools for analysis. Of those who are not seeing positive results with FDA, data volume analyzed is low, with only a small minority of respondents analyzing more than 1 million records. Companies are likely to see better results from their FDA tools when they start applying them to more of their data. Figure 13: Data volume used in FDA Under 1 million 23% 53% Between 57% 1 million and 10 million 19% More than 10 million 79% 11% Agree Disagree �▀ ▀ Q. What data volume (in records) do you typically work with in your FDA tasks? Among all respondents (665), 56% (370) agree and 21% (140) disagree that “We currently get positive results from the FDA tools that we use.” Multiple answers allowed, may exceed 100%. Global Forensic Data Analytics Survey 2016 | 25

Shifting into High Gear: Mitigating Risks and Demonstrating Returns - Page 25 Shifting into High Gear: Mitigating Risks and Demonstrating Returns Page 24 Page 26

Next in

Next in